Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
Apyx Medical Corporation (NASDAQ:APYX), a leader in advanced energy technology, announced its participation in the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, in Boston, MA.
CEO Charlie Goodwin and CFO Matt Hill will conduct a fireside chat at 4:00pm ET and hold one-on-one investor meetings throughout the day. The presentation will be available via live webcast with a replay option on the company's investor relations website.
Apyx Medical specializes in Helium Plasma Platform Technology, marketing Renuvion® and AYON Body Contouring System™ for cosmetic surgery and J-Plasma® for hospital surgical markets, with efficacy supported by over 90 clinical publications.
[]Apyx Medical Corporation (NASDAQ:APYX), leader nelle tecnologie avanzate per l'energia, ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Crescita di Canaccord Genuity il 12 agosto 2025 a Boston, MA.
Il CEO Charlie Goodwin e il CFO Matt Hill terranno una conversazione informale alle 16:00 ET e parteciperanno a incontri individuali con investitori durante tutta la giornata. La presentazione sarà disponibile in diretta streaming con la possibilità di rivederla sul sito web delle relazioni con gli investitori dell'azienda.
Apyx Medical è specializzata nella tecnologia della Piattaforma a Plasma di Elio, commercializzando Renuvion® e AYON Body Contouring System™ per la chirurgia estetica e J-Plasma® per il settore chirurgico ospedaliero, con l'efficacia supportata da oltre 90 pubblicazioni cliniche.
Apyx Medical Corporation (NASDAQ:APYX), líder en tecnología avanzada de energía, anunció su participación en la 45ª Conferencia Anual de Crecimiento de Canaccord Genuity el 12 de agosto de 2025 en Boston, MA.
El CEO Charlie Goodwin y el CFO Matt Hill realizarán una charla informal a las 4:00 pm ET y mantendrán reuniones individuales con inversores durante todo el día. La presentación estará disponible mediante webcast en vivo con opción de repetición en el sitio web de relaciones con inversores de la compañía.
Apyx Medical se especializa en la Tecnología de Plataforma de Plasma de Helio, comercializando Renuvion® y AYON Body Contouring System™ para cirugía estética y J-Plasma® para mercados quirúrgicos hospitalarios, con eficacia respaldada por más de 90 publicaciones clínicas.
Apyx Medical Corporation (NASDAQ:APYX)는 첨단 에너지 기술 분야의 선두주자로서 2025년 8월 12일 매사추세츠주 보스턴에서 열리는 Canaccord Genuity 제45회 연례 성장 컨퍼런스에 참가한다고 발표했습니다.
CEO 찰리 굿윈과 CFO 매트 힐은 오후 4시(동부시간)에 화기애애한 대화 세션을 진행하며, 하루 종일 1:1 투자자 미팅을 가질 예정입니다. 발표 내용은 회사 투자자 관계 웹사이트를 통해 생중계되며 다시보기 서비스도 제공됩니다.
Apyx Medical은 헬륨 플라즈마 플랫폼 기술을 전문으로 하며, 미용 수술용 Renuvion® 및 AYON Body Contouring System™과 병원 수술 시장용 J-Plasma®를 마케팅하고 있으며, 90건 이상의 임상 출판물로 효능이 입증되어 있습니다.
Apyx Medical Corporation (NASDAQ:APYX), un leader dans la technologie énergétique avancée, a annoncé sa participation à la 45e conférence annuelle sur la croissance de Canaccord Genuity le 12 août 2025 à Boston, MA.
Le PDG Charlie Goodwin et le directeur financier Matt Hill animeront une discussion informelle à 16h00 ET et tiendront des réunions individuelles avec des investisseurs tout au long de la journée. La présentation sera disponible en webdiffusion en direct avec une option de rediffusion sur le site des relations investisseurs de la société.
Apyx Medical est spécialisée dans la technologie de plateforme plasma à l’hélium, commercialisant Renuvion® et AYON Body Contouring System™ pour la chirurgie esthétique et J-Plasma® pour les marchés chirurgicaux hospitaliers, avec une efficacité soutenue par plus de 90 publications cliniques.
Apyx Medical Corporation (NASDAQ:APYX), ein führendes Unternehmen im Bereich fortschrittlicher Energietechnologie, gab seine Teilnahme an der 45. jährlichen Wachstumskonferenz von Canaccord Genuity am 12. August 2025 in Boston, MA, bekannt.
CEO Charlie Goodwin und CFO Matt Hill werden um 16:00 Uhr ET ein informelles Gespräch führen und den ganzen Tag Einzelgespräche mit Investoren abhalten. Die Präsentation wird per Live-Webcast mit einer Wiederholungsoption auf der Investor-Relations-Website des Unternehmens verfügbar sein.
Apyx Medical spezialisiert sich auf die Helium-Plasma-Plattform-Technologie und vermarktet Renuvion® und AYON Body Contouring System™ für die Schönheitschirurgie sowie J-Plasma® für den chirurgischen Krankenhausmarkt, wobei die Wirksamkeit durch über 90 klinische Veröffentlichungen unterstützt wird.
- None.
- None.
CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that management will participate in the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, in Boston, MA.
Charlie Goodwin, the Company’s President and Chief Executive Officer, and Matt Hill, the Company’s Chief Financial Officer, will participate in a fireside chat on Tuesday, August 12, 2025, at 4:00pm ET and will hold one-on-one meetings with investors throughout the day. The fireside chat will be accessible via live webcast here, and a replay will be available on the Events section of Apyx Medical’s Investor Relations website at https://apyxmedical.com/investor_relations/.
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® and now the AYON Body Contouring System™ in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical publications. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com
Investor Relations Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
OP: 212-915-2568
jfeffer@lifesciadvisors.com
FAQ
When is Apyx Medical (NASDAQ:APYX) presenting at the Canaccord Genuity Conference?
Who will represent Apyx Medical at the Canaccord Genuity Conference?
How can investors access Apyx Medical's Canaccord conference presentation?
What are Apyx Medical's main products in the medical device market?
How many clinical publications support Apyx Medical's technology?
